'Comparable' Efficacy and Safety for Trastuzumab Biosimilar - Medscape

Medscape

'Comparable' Efficacy and Safety for Trastuzumab Biosimilar Medscape CHICAGO — A biosimilar to trastuzumab (Herceptin, Genentech/Roche) could be coming soon. The product, Myl-1401O (Mylan NV), has efficacy and safety comparable to the branded product, according to new findings presented here at the American ... Mylan, Biocon's PhIII success for Herceptin knockoff threatens anchor drug for RocheFierceBiotech Study Finds Mylan's 'Biosimilar' Drug Comparable to Roche Cancer MedicineWall Street Journal Cheaper Breast Cancer Drug Does Well in Clinical TrialU.S. News & World Report Reuters -OncLive -Cancer Network -StreetInsider.com all 25 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNGCRf4u9IElo8-eg0PTuGyaMS6UfA&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779126286493&ei=LkpTV9jiG4qV3AGFn4u4Dw&url=http://www.medscape.com/viewarticle/864315
via IFTTT